Schedule 13G ownership disclosure

BENITEC BIOPHARMA INC

Security class unavailable · CUSIP: 08205P100

Event date: 2023-08-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
98,203
Percent of class
3.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-093323
Form type
SC 13G/A
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Aug 18, 2023
Reporting period
Aug 08, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub